Streetbeat News

Products Services

PRFX

PainReform Ltd. (NASDAQ:PRFX) has announced a significant advancement in the development of its lead asset, PRF-110. The company has developed a new manufacturing process that allows PRF-110 to remain stable for 18 months at room temperature, a major milestone for the clinical-stage specialty pharmaceutical company.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:39 pm

MBRX

Moleculin Biotech, Inc. (NASDAQ: MBRX) announced plans for a pivotal, adaptive Phase 3 clinical trial (MIRACLE trial) for the possible accelerated approval of Annamycin in combination with Cytarabine for treating relapsed or refractory AML. The decision follows a positive discussion with the FDA.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:36 pm

COIN

Vice President Kamala Harris is pivoting towards the cryptocurrency sector to gain support from Silicon Valley's tech community, as her chances of winning the 2024 presidential race stand at 43% according to Polymarket. Her campaign has reached out to Bitcoin advocate Mark Cuban and is considering meetings with industry giants like Ripple, Coinbase, and Circle.

Portfolio Pulse from Murtuza Merchant

August 01, 2024 | 12:35 pm

SLP

Simulations Plus has released an updated version of its QST software, DILIsym Version X, which is designed to investigate and predict drug-induced liver injury.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:35 pm

GH

Guardant Health has announced FDA approval and Medicare coverage for its Shield blood test, which is now commercially available as the first FDA-approved blood test for primary colorectal cancer screening.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:33 pm

NVTS

Navitas Semiconductor has extended its Gen-3 'Fast' 650V SiC MOSFETs into a thermally-enhanced TOLL package, targeting high-power and high-reliability applications.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:32 pm

AAPL

Apple Inc (NASDAQ:AAPL) will release its Q3 earnings on Aug. 1. Investors are eyeing potential gains from Apple's dividends, which currently yield 0.45%. To earn $500 monthly from dividends, an investor would need approximately $1,332,480 worth of Apple shares. Analysts expect Apple to report earnings of $1.35 per share and revenue of $84.53 billion. Apple's streaming results and potential ad-supported plans are also under scrutiny.

Portfolio Pulse from Avi Kapoor

August 01, 2024 | 12:26 pm

BYDDF

FXI

TSLA

BYD reported July vehicle sales of 342,383 units, with passenger vehicle sales at 340,799 units. Plug-in hybrid passenger EV sales were 210,799 units, and battery passenger EV sales were 130,000 units.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:19 pm

LLY

Eli Lilly shares are trading higher following the announcement of positive topline results from the SUMMIT phase 3 clinical trial for tirzepatide injection in adults with heart failure with preserved ejection fraction and obesity.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:15 pm

ATNM

Actinium Pharmaceuticals has received a U.S. patent extending into 2040, covering methods using Iomab-ACT for conditioning patients prior to gene-edited hematopoietic stem cell therapy for non-malignant disorders.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:15 pm